Identification of a luminescent platinum(II) complex with BODIPY derivative as novel photodynamic therapy agent for triple negative breast cancer cells
- 9 February 2023
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 242, 112160
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mitochondrial–Nuclear Communication by Prohibitin Shuttling under Oxidative StressBiochemistry, 2011
- In Vitro and In Vivo Photocytotoxicity of Boron Dipyrromethene Derivatives for Photodynamic TherapyJournal of Medicinal Chemistry, 2010
- Porphyrin derivatives as photosensitizers for the inactivation ofBacillus cereusendosporesJournal of Applied Microbiology, 2009
- Forkhead Box m1 transcription factor is required for perinatal lung functionProceedings of the National Academy of Sciences, 2008
- Ruthenium Porphyrin Compounds for Photodynamic Therapy of CancerJournal of Medicinal Chemistry, 2008
- Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair GenesMolecular and Cellular Biology, 2007
- Highly Efficient and Photostable Photosensitizer Based on BODIPY ChromophoreJournal of the American Chemical Society, 2005
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photodynamic Therapy-induced Apoptosis in Epidermoid Carcinoma CellsJournal of Biological Chemistry, 2001
- Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumoursCytometry, 1995